Log in to the Sina Finance APP and search for [Xinphi] to see more evaluation grades

"Science and Technology Innovation Board Daily" on March 14 The main contents of today's Science and Technology Innovation Board Evening News include: "Measures for the Identification of Artificial Intelligence Generated and Synthetic Content" will come into force on September 1; Shanghai: Do a good job in unveiling the 2025 artificial intelligence medical device innovation task; Xiamen: Promote the introduction of "Several Measures to Further Promote the High-quality Development of Marine Economy".

[Hot Spotlight].

News-in-brief:

The Measures for the Identification of Artificial Intelligence Generated and Synthetic Content were promulgated and came into force on September 1

The Cyberspace Administration of China and other four departments issued the "Measures for the Identification of Artificial Intelligence Generated and Synthetic Content". It is proposed that the Cyberspace Administration of China and other four departments issued the "Measures for the Identification of Artificial Intelligence Generated Synthetic Content", which mentions that the identification of artificial intelligence-generated synthetic content mainly includes two forms: explicit identification and implicit identification, and explicit identification refers to the identification added in the generated synthetic content or interactive scene interface, presented in the form of text, sound, graphics, etc., and can be clearly perceived by users; Implicit identification refers to the identification that is added to the data generated by the synthetic content file by technical measures, and is not easily perceived by the user. These Measures shall come into force on September 1, 2025.

Four departments, including the Cyberspace Administration of China, are encouraged to encourage service providers to add implicit signs in the form of digital watermarks to the generated synthetic content

The Cyberspace Administration of China and four other departments issued the Measures for the Identification of Artificial Intelligence Generated Synthetic Content, which mentions that service providers are encouraged to add implicit signs in the form of digital watermarks to the generated synthetic content. Where users apply for service providers to provide generated and synthesized content that does not have explicit identifiers attached, the service provider may, after clarifying the user's identification obligations and responsibilities through the user agreement, provide the generated and synthetic content without explicit identifiers, and lawfully retain relevant logs such as the information of the recipients of the provision for at least 6 months.

Shanghai: Do a good job in unveiling the 2025 artificial intelligence medical device innovation task

The Shanghai Municipal Commission of Economy and Information Technology and the Shanghai Municipal Drug Administration issued a notice on doing a good job in unveiling the list of artificial intelligence medical device innovation tasks in 2025, facing three categories: intelligent assisted decision-making products, brain-computer hybrid intelligent products, and support environment, focusing on intelligent auxiliary diagnostic and testing products, intelligent surgical robots, intelligent digital therapy products, intelligent auxiliary monitoring and life support products, intelligent assisted decision-making products, brain-computer interface intelligent diagnosis and treatment and rehabilitation products for nerve injuries and nervous system diseases, There are 9 unveiling directions, including brain-computer hybrid intelligent products, medical artificial intelligence databases, and medical scientific and technological achievements transformation centers (see the attached notice for application guidelines), and a group of units with strong innovation capabilities will be collected and selected to focus on tackling key problems, promote the innovation and development of artificial intelligence medical devices, and accelerate the application of new technologies and new products.

Xiamen: Promote the introduction of "Several Measures to Further Promote the High-quality Development of the Marine Economy" to accelerate the construction of a national marine economic development demonstration zone

It was learned from the Xiamen Marine Development Bureau that this year, Xiamen will continue to strengthen the leading role of policies, promote the introduction of "Several Measures to Further Promote the High-quality Development of the Marine Economy", and increase support from scientific research and innovation, industrial development, talent cultivation, support system and investment promotion. A new round of development planning is also in full swing, will focus on the construction of the national marine economic development demonstration zone target requirements, start the "Xiamen marine economic development "15th Five-Year Plan" preparation and organization of implementation, carefully plan the new five-year development ideas. At the same time, it is also necessary to revise the "Xiamen Marine and Fishery Special Fund Management Measures" and strive to introduce more effective industrial support policies.

It is rumored that Huawei notebooks are no longer available for Windows Insider: The license of the US Department of Commerce has not been renewed when it expires

A few days ago, there was news in the market that the supply license of Microsoft's Windows operating system to Huawei will expire this month, and then Huawei's PC can only use the national production plan, that is, to launch PC products using domestic chips + domestic operating systems. In this regard, a Huawei insider confirmed to reporters: "The license given by the U.S. Department of Commerce has expired and has not been renewed." ”

Depth:

Why develop a deep-sea economy? Where is the development potential? The agency quickly interpreted

[Announcement of the Science and Technology Innovation Board].

Wonders: The actual controller plans for matters that may lead to a change of control of the company The stock is suspended

Wonders (688178.SH) announced that the actual controller of the company is planning a major event, which may lead to a change of control of the company. In order to ensure fair information disclosure, safeguard the interests of investors, and avoid abnormal fluctuations in the company's stock price, the company's shares will be suspended from March 17, 2025, and the suspension time is expected to be no more than 2 trading days.

Xinxiangwei: It is planned to purchase 100% of the shares of Aixiesheng and the shares will resume trading next Monday

Xinxiangwei (688593.SH) announced that the company intends to purchase 100% of the equity of Shenzhen Aixiesheng Technology Co., Ltd. through the issuance of shares, convertible corporate bonds and cash payment, and issue shares to no more than 35 specific investors to raise matching funds. The company's shares will be suspended from the market open on March 3, 2025, and will resume trading from the market open on March 17, 2025. Since the audit and evaluation of the assets involved in this transaction have not been completed, the company decided not to convene a general meeting of shareholders to consider the transaction for the time being. Aixiesheng is mainly engaged in the research and development, design and sales of various chip products such as display driver chips and touch driver chips.

Youyan Silicon: plans to acquire 70% of the equity of DGT

The company announced that the company intends to acquire 70% of the shares of DGTechnologies Co., Ltd. held by RSTechnologies Co., Ltd. through cash payment with its own funds. After the completion of the acquisition, the company will hold 70% of the equity of DGT, RST will continue to hold 30% of the equity of DGT, and DGT will become a holding subsidiary of the company and be included in the consolidated scope of the company's consolidated financial statements.

Zhongke Tongda: Matters related to the purchase of equity are being planned, and the stock continues to be suspended

Zhongke Tongda (688038.SH) announced that the company is planning to purchase 100% of the shares of Xinghe Power (Beihai) Technology Co., Ltd. by issuing shares and paying cash and raising matching funds, the company's shares will be suspended from the opening of the market on the morning of March 10, 2025, and the suspension is expected to last no more than 5 trading days. The relevant parties are actively promoting the work of this transaction, and the company does not expect to be able to resume trading from the opening of the market on the morning of March 17 (Monday). After the company's application, the company's shares have been suspended since the market opened on the morning of March 17, and it is expected that the suspension will continue to last no more than 5 trading days.

Espressif Technology: It is planned to raise no more than 1.778 billion yuan

Espressif Systems (688018.SH) announced that the company intends to issue shares to specific targets to raise a total of no more than 1.778 billion yuan, and the net amount after deducting the issuance expenses is intended to be invested in the R&D and industrialization of Wi-Fi 7 router chips, the R&D and industrialization of Wi-Fi 7 smart terminal chips, the R&D and industrialization of AI end-side chips based on RISC-V self-developed IP, the construction project of Shanghai R&D center and supplementary working capital.

EFORT: Completed the change of company name to "EFORT Intelligent Robot Co., Ltd."

EFORT (688165.SH) announced that the company has completed the industrial and commercial change registration procedures and obtained the business license renewed by the Wuhu Municipal Market Supervision and Administration Bureau. The Chinese name of the company was officially changed from "EFORT Intelligent Equipment Co., Ltd." to "EFORT Intelligent Equipment Co., Ltd.", and the English name was changed from "EFORT Intelligent Equipment Co., Ltd." Changed to EFORT Intelligent Robot Co., Ltd. This change does not affect the company's stock abbreviation and stock code.

Peneng Technology: Shareholder Rongke Venture Capital plans to reduce its holdings of no more than 3% of the company's shares

Peneng Technology (688063.SH) announced that the company's shareholder Rongke Venture Capital plans to reduce the total number of shares of the company through centralized bidding and block trading not more than 7,360,776 shares due to its own capital turnover needs, and the reduction ratio does not exceed 3% of the company's total share capital.

UCD: China Mobile Capital plans to reduce its holdings of no more than 1.50% of the company's shares

UCD (688158.SH) announced that the shareholder China Mobile Capital plans to reduce its holdings of the company's shares by no more than 6,796,425 shares, that is, no more than 1.50% of the company's total share capital, through centralized bidding, block trading and other legal methods recognized by the Shanghai Stock Exchange. The reduction period is 3 months after 15 trading days from the date of disclosure of the announcement. China Mobile Capital promises not to transfer or entrust others to manage the shares of the issuer directly or indirectly held by it before the issuance and listing within 12 months from the date of listing and trading of the issuer's shares.

Sirui New Materials: The company's controlling shareholders and actual controllers promised not to reduce their holdings of the company's shares in the next 12 months

Sirui New Materials (688102.SH) announced that the company received the "Letter of Commitment on Voluntary Non-Reduction" issued by Wang Wenbin, the controlling shareholder, actual controller and chairman, Sheng Qingyi, a shareholder and director of more than 5% of the shares, and Shenzhen Leran Technology Development Co., Ltd., which acted in concert. Based on his confidence in the company's future development prospects and recognition of the company's long-term value, Wang Wenbin voluntarily promised not to reduce his holdings of the company's shares in the next 12 months from March 16, 2025; Sheng Qingyi and its concerted actor, Shenzhen Leran Technology Development Co., Ltd., also voluntarily undertook not to reduce their holdings of the company's shares in any way during the same period.

Huaguang New Materials: It plans to invest 300 million yuan to build a production base in Thailand

Huaguang New Materials (688379.SH) announced that the company plans to set up a wholly-owned subsidiary in Thailand to invest in the construction of a brazing material production base in Thailand, with a total investment of about 300 million yuan. The project will be constructed in two phases, the first phase will build a production line with a capacity of 1,000 tons by leasing a plant, and the second phase will build a production line with a capacity of 3,500 tons by purchasing land to build a new plant.

United Imaging Medical: Shareholders plan to inquire about the transfer of 3.53% of the shares

United Imaging Medical (688271.SH) announced that shareholders Zhongke State Street and Beiyuan Investment plan to reduce their holdings by a total of 29,086,400 shares, accounting for 3.53% of the company's total share capital, through inquiry and transfer, and the reason for the reduction is their own capital needs. The transferor promises that the shares held by it have been lifted, the ownership is clear, and there is no situation where the shareholding cannot be reduced. The minimum transfer price shall not be less than 70% of the average stock trading price in the 20 trading days prior to the date of sending the subscription invitation, which will be organized and implemented by China International Capital Corporation Limited. The transferee must be an institutional investor with appropriate pricing power and risk tolerance.

Yuandong Biological: Dihydroxypropylphylline injection obtained the drug registration certificate

Yuandong Biology (688513.SH) announced that the company recently received the "Drug Registration Certificate" approved and issued by the State Food and Drug Administration, with the drug name of dihydroxypropylphylline injection and the dosage form of injection, with a specification of 2ml: 0.3g. The drug belongs to the 3rd category of chemical drugs, which is suitable for relieving wheezing symptoms such as bronchial asthma, wheezing bronchitis, and obstructive emphysema. According to the data of Minenet, the sales volume of terminal dihydroxypropylphylline injection in China's urban public hospitals will be about 88 million yuan in 2023. The company's drug was approved for marketing according to the new classification, and after approval, it is deemed to have passed the consistency evaluation. The period from the approval of drugs to the production and sale of drugs may be affected by some uncertain factors, and the company will fulfill its information disclosure obligations in accordance with the provisions of relevant laws and regulations.

[Venture capital vane].

Visual Perception Intelligence completed the A+ round of financing

Recently, Beijing Visual Perception Intelligent Technology Co., Ltd. completed the A+ round of financing, and the investor in this round is Hongchuang Capital. Visual Perception Intelligence is a developer of integrated equipment for intelligent diagnosis and treatment of real-time dynamic ultrasound images. According to the data of the Venture Capital Connect of the Financial Associated Press, taking March 2025 as the forecast base time, the financing forecast probability for the next two years is 63.78%.

Qianjue Technology received tens of millions of yuan in Pre-A round of financing

Recently, Beijing Qianjue Technology Co., Ltd. completed tens of millions of yuan in Pre-A round of financing, which was jointly led by Chase Venture Capital and Detong Capital, and followed by Jingye Intelligent Industry Fund. Founded in 2023, Qianjue Technology is engaged in the research and development and application of large models for decision-making and planning. Qianjue Technology has previously completed multiple rounds of financing, with an angel round financing amount of tens of millions of yuan, and investors include well-known institutions GGV Capital and Chenhui Venture Capital. According to the data of the Venture Capital Connect of the Financial Associated Press, taking March 2025 as the forecast base time, the financing forecast probability for the next two years is 79.56%.

Kentuo Fluid received C+ round of investment from Fengnian Capital

Recently, Shenzhen Kentuo Fluid Technology Co., Ltd. completed the C+ round of financing, and the investor in this round is Fengnian Capital. Kentuo Fluid, a precision fluid control system and components company, has completed multiple rounds of financing since its establishment in 2010. The angel round of financing was led by GGV Capital and Chenhui Venture Capital, and the Series A and Series A+ financing were followed by Tongchuangweiye and Yida Capital. Series B and Series B+ financing introduced institutions such as CICC Capital and Oriental Fuhai. The Series C financing was co-invested by Dachen Caizhi and Source Code Capital. The company's STAR Market IPO was accepted in December 2023 and terminated in June 2024. According to the data of the Venture Capital Connect of the Financial Associated Press, taking March 2025 as the forecast base time, the company's financing forecast probability for the next two years is 63.68%.